ABUS ARBUTUS BIOPHARMA CORP
FollowCommon Shares, without par value (common), issuer CIK 1447028
Filings received so far for Q3 2026: 5 13F filers report a position in ABUS shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- Roivant Sciences Ltd.
29,880,079 shares, 19.5% in a 13D/A as of 2026-10-01,0001140361-26-038693
Accepted , ingested - MORGAN STANLEY(group MORGAN STANLEY)
18,682,708 shares, 12.2% in a 13G/A as of 2026-09-30,0000895421-26-000284
Accepted , ingested
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Beardsley Robert Adirector | 2026-10-01 | -17,948 D | $5 | Form 4 |
| Nguyen Tuanofficer (Chief Financial Officer) | 2026-10-01 | -48,081 D | $5 | Form 4 |
| Sawhney Rogerdirector | 2026-10-01 | -17,142 D | $5 | Form 4 |
| Androski Lindsaydirector, officer (President and CEO) | 2026-10-01 | -24,655 D | $5 | Form 4 |
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Two Seas Capital LPin group Two Seas Capital LP | 8,143,994 | $38.9M | 1.55% | -10,951,589 | 13F-HRTimelineGroup |
| Ledgewood Wealth Advisors, LLC | 278,436 | $1.33M | 0.73% | 0 | 13F-HRTimeline |
| EASTERN BANK | 5,000 | $23.9K | <0.01% | 0 | 13F-HRTimeline |
| GAMMA Investing LLC | 182 | $870 | <0.01% | -46 | 13F-HRTimeline |
| Farther Finance Advisors, LLC | 136 | $650 | <0.01% | new | 13F-HRTimeline |
Events
MORGAN STANLEY and 1 other reporting person reported 18,682,708 ABUS shares, 12.2% of the class, as of 2026-09-30, in a 13G/A filed 2026-10-07. 0000895421-26-000284
Accepted , ingestedBeardsley Robert A disposed of 17,948 ABUS shares on 2026-10-01, Form 4 filed 2026-10-07. 0001447028-26-000061
Accepted , ingestedNguyen Tuan disposed of 48,081 ABUS shares on 2026-10-01, Form 4 filed 2026-10-07. 0001447028-26-000060
Accepted , ingestedSawhney Roger disposed of 17,142 ABUS shares on 2026-10-01, Form 4 filed 2026-10-07. 0001447028-26-000059
Accepted , ingestedAndroski Lindsay disposed of 24,655 ABUS shares on 2026-10-01, Form 4 filed 2026-10-07. 0001447028-26-000058
Accepted , ingestedRoivant Sciences Ltd. reported 29,880,079 ABUS shares, 19.5% of the class, as of 2026-10-01, in a 13D/A filed 2026-10-05. 0001140361-26-038693
Accepted , ingested